Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib

Abstract : Sorafenib is the treatment of reference for advanced hepatocellular carcinoma (HCC). A decrease in the serum levels of Alpha-fetoprotein (AFP) is reported to be the biological parameter that is best associated with disease control by sorafenib. In order to provide a biological rationale for the variations of APP, we analyzed the various steps of AFP production in human HCC cell lines exposed to sorafenib. Sorafenib dramatically reduced the levels of APP produced by HCC cells independently of its effect on cell viability. The mRNA levels of APP decreased upon sorafenib treatment, while the AFP protein remained localized in the Golgi apparatus. Sorafenib activated the Regulated Inositol-Requiring Enzyme-1 alpha (IRE-1 alpha) and the PKR-like ER Kinase (PERK)-dependent arms of the Unfolded Protein Response (UPR). The inhibition of IRE-1 alpha partially restored the mRNA levels of AFP upon treatment with sorafenib. The inhibition of both pathways partially prevented the drop in the production of AFP induced by sorafenib. The findings provide new insights on the regulation of APP, and identify it as a biomarker suitable for the exploration of HCC cell proteostasis in the context of therapeutic targeting. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03592366
Contributeur : Louise Dessaivre Connectez-vous pour contacter le contributeur
Soumis le : mardi 1 mars 2022 - 11:37:13
Dernière modification le : mardi 17 mai 2022 - 10:26:13

Identifiants

Citation

Aline Houessinon, Albane Gicquel, Flora Bochereau, Christophe Louandre, Remy Nyga, et al.. Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib. Cancer Letters, Elsevier, 2016, 370 (2), pp.242-249. ⟨10.1016/j.canlet.2015.10.032⟩. ⟨hal-03592366⟩

Partager

Métriques

Consultations de la notice

10